ENDRA Life Sciences (NDRA) Non Operating Income (2017 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Non Operating Income of $862315.0 for Q1 2026, up 99.17% year-over-year from $432952.0 in Q1 2025, and up 155.73% quarter-over-quarter from -$1.5 million in Q4 2025.
ENDRA Life Sciences (NDRA) Non Operating Income (2017 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Non Operating Income for 10 consecutive years, with $862315.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 99.17% year-over-year to $862315.0; the TTM figure through Mar 2026 stood at -$477172.0 (down 81.65% YoY), while the FY2025 annual figure was -$1.3 million, down 83.02% from the prior year.
- Non Operating Income advanced to $862315.0 in Q1 2026 per NDRA's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Non Operating Income topped out at $862315.0 in Q1 2026 and bottomed at -$1.5 million in Q4 2025.
- Historically, Non Operating Income has averaged -$48924.1 across 5 years, with a median of -$1756.0 in 2023.
- On a YoY basis, Non Operating Income climbed as much as 8513.15% in 2024 and fell as far as 3093.96% in 2024.
- ENDRA Life Sciences' Non Operating Income stood at $23785.0 in 2022, then tumbled by 107.38% to -$1756.0 in 2023, then jumped by 8513.15% to $147735.0 in 2024, then plunged by 1147.27% to -$1.5 million in 2025, then soared by 155.73% to $862315.0 in 2026.
- Business Quant data shows NDRA's Non Operating Income at $862315.0 in Q1 2026, -$1.5 million in Q4 2025, and -$225256.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 15.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Mn |
| Mar 31, 2026 | 862,315.00 |
| Dec 31, 2025 | -1.55 Mn |
| Sep 30, 2025 | -225,256.00 |
| Jun 30, 2025 | 75,178.00 |
| Mar 31, 2025 | 432,952.00 |
| Dec 31, 2024 | 147,735.00 |
| Sep 30, 2024 | -845,076.00 |
| Jun 30, 2024 | 1,700.00 |
| Dec 31, 2023 | -1,756.00 |
| Sep 30, 2023 | 28,226.00 |
| Jun 30, 2023 | 437,433.00 |
| Mar 31, 2023 | -3,418.00 |
| Dec 31, 2022 | 23,785.00 |
| Sep 30, 2022 | -23,011.00 |
| Jun 30, 2022 | -19,374.00 |
| Mar 31, 2022 | -2,933.00 |
| Dec 31, 2021 | -33,087.00 |
| Sep 30, 2021 | -7,507.00 |
| Jun 30, 2021 | 1,086.00 |